Patricia L. Morris

Array ( [id] => 6725757 [patent_doc_number] => 20030208069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Method for producing 8-methoxy-quinoline carboxylic acids' [patent_app_type] => new [patent_app_number] => 10/406129 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3449 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20030208069.pdf [firstpage_image] =>[orig_patent_app_number] => 10406129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642367 [patent_doc_number] => 20030212274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Novel amorphous form of omeprazole salts' [patent_app_type] => new [patent_app_number] => 10/276875 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1546 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212274.pdf [firstpage_image] =>[orig_patent_app_number] => 10276875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281581 [patent_doc_number] => 20040063958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Synthesis of 2, 6-dicarboxylpyridines' [patent_app_type] => new [patent_app_number] => 10/405464 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1808 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063958.pdf [firstpage_image] =>[orig_patent_app_number] => 10405464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702264 [patent_doc_number] => 20030225144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Novel crystalline forms of a factor Xa inhibitor' [patent_app_type] => new [patent_app_number] => 10/404678 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9576 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225144.pdf [firstpage_image] =>[orig_patent_app_number] => 10404678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075366 [patent_doc_number] => 20050148634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => '1-N-Aminobenzimidazole derivatives' [patent_app_type] => utility [patent_app_number] => 10/507361 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26457 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148634.pdf [firstpage_image] =>[orig_patent_app_number] => 10507361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963841 [patent_doc_number] => 06949653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-27 [patent_title] => 'Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone' [patent_app_type] => utility [patent_app_number] => 10/400780 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4209 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949653.pdf [firstpage_image] =>[orig_patent_app_number] => 10400780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931773 [patent_doc_number] => 20050282808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Benzofuran derivative' [patent_app_type] => utility [patent_app_number] => 10/508512 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48989 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282808.pdf [firstpage_image] =>[orig_patent_app_number] => 10508512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265661 [patent_doc_number] => 06660861 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Process for preparing Topotecan from 10-hydroxy-4-(S) camptothecin' [patent_app_type] => B1 [patent_app_number] => 10/401119 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4392 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660861.pdf [firstpage_image] =>[orig_patent_app_number] => 10401119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809616 [patent_doc_number] => 20030199555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Indoline compounds and to pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 10/400358 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4393 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199555.pdf [firstpage_image] =>[orig_patent_app_number] => 10400358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7451908 [patent_doc_number] => 20040010151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Lansoprazole polymorphs and processes for preparation thereof' [patent_app_type] => new [patent_app_number] => 10/401057 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4634 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010151.pdf [firstpage_image] =>[orig_patent_app_number] => 10401057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967206 [patent_doc_number] => 20050234103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Crystalline forms of rabeprazole sodium' [patent_app_type] => utility [patent_app_number] => 10/505826 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4323 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234103.pdf [firstpage_image] =>[orig_patent_app_number] => 10505826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098568 [patent_doc_number] => 20050131027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Fine particle size pioglitazone' [patent_app_type] => utility [patent_app_number] => 10/508741 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2942 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131027.pdf [firstpage_image] =>[orig_patent_app_number] => 10508741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189472 [patent_doc_number] => 06734309 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Process for the synthesis of isonicotinic acid hydrazide' [patent_app_type] => B1 [patent_app_number] => 10/393372 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1103 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734309.pdf [firstpage_image] =>[orig_patent_app_number] => 10393372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645519 [patent_doc_number] => 07119107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Pyridone derivatives' [patent_app_type] => utility [patent_app_number] => 10/505476 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11308 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119107.pdf [firstpage_image] =>[orig_patent_app_number] => 10505476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246307 [patent_doc_number] => 06677464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Process for preparation of 7-oxabicyclo2.2.1hept-5-ene-2-carboxylic acid derivatives' [patent_app_type] => B2 [patent_app_number] => 10/363857 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6184 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677464.pdf [firstpage_image] =>[orig_patent_app_number] => 10363857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330099 [patent_doc_number] => 20040254211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Alpha v integrin receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/380245 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9926 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254211.pdf [firstpage_image] =>[orig_patent_app_number] => 10380245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1157119 [patent_doc_number] => 06765095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-20 [patent_title] => '2,3-disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor' [patent_app_type] => B2 [patent_app_number] => 10/383586 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20379 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/765/06765095.pdf [firstpage_image] =>[orig_patent_app_number] => 10383586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809615 [patent_doc_number] => 20030199554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => '2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor' [patent_app_type] => new [patent_app_number] => 10/383585 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20645 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199554.pdf [firstpage_image] =>[orig_patent_app_number] => 10383585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822144 [patent_doc_number] => 20030220305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Alkylene-tethered bis-nitroiminoimidazolidines, process for preparing the same, and insecticides containing the same' [patent_app_type] => new [patent_app_number] => 10/379641 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5125 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220305.pdf [firstpage_image] =>[orig_patent_app_number] => 10379641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892298 [patent_doc_number] => 07345061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Alkylammonium salts of omeprazole and esomeprazole' [patent_app_type] => utility [patent_app_number] => 10/506345 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4194 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345061.pdf [firstpage_image] =>[orig_patent_app_number] => 10506345 [rel_patent_id] =>[rel_patent_doc_number] =>)